Insulin and high glucose modulation of phosphatase and reductase enzymes in the human erythrocytes: A comparative analysis in normal and diabetic states

Diabetes Research and Clinical Practice

Volumn 47, Issue 3, 2000, Pages 191-198

  Marques, Fernanda ^a   Crespo, Maria E ^b,c   Silva, Zelinda I ^b   Bicho, Manuel ^b  

^a INSTITUTO TECNOLÓGICO E NUCLEAR   (Portugal)

^b INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^c Portuguese Cancer Institute   (Portugal)

Author keywords

Diabetes mellitus; Glucose; Human erythrocytes; Insulin; Insulin receptor phosphorylation; Phosphatase activity

Indexed keywords

ACID PHOSPHATASE; CYTOCHROME B5 REDUCTASE; GLYCOSYLATED HEMOGLOBIN; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR KINASE; OXIDOREDUCTASE; PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE; SULFONYLUREA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; GLYCOLYSIS; HUMAN; HUMAN CELL; MALE; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ACID PHOSPHATASE; ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ERYTHROCYTES; FEMALE; GLUCOSE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; KINETICS; MALE; MIDDLE AGED; NADH, NADPH OXIDOREDUCTASES; PROTEIN-TYROSINE-PHOSPHATASE; REFERENCE VALUES;

EID: 0033964923     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(99)00128-X     Document Type: Article

References (37)

1. Grigorescu F., Flier J.S., Kahn C.R. Defect in insulin receptor phosphorylation in erythrocytes and fibroblasts associated with severe insulin resistance. J. Biol. Chem. 259:1984;15003-15006.
2. Moller D.E., Flier J.S. Insulin resistance-mechanisms, syndromes, and implications. N. Engl. J. Med. 325:1991;938-948.
3. Häring H.U. The insulin receptor: signalling mechanism and contribution to the pathogenesis of insulin resistance. Diabetologia. 34:1991;848-861.
4. Ide R., Maegawa H., Kikkawa R., Shigeta Y., Kashiwagi A. High glucose condition activates protein tyrosine phosphatases and deactivates insulin receptor function in insulin-sensitive rat 1 fibroblasts. Biochem. Biophys. Res. Commun. 201:1994;71-77.
5. McGuire M.C., Fields R.M., Nyomba B.L., Raz I., Bogardus C., Tonks N.K., Sommercorn J. Abnormal regulation of protein tyrosine phosphatase activities in skeletal muscle of insulin-resistant humans. Diabetes. 40:1991;939-942.
6. Goldstein B.J. Protein-tyrosine phosphatases and the regulation of insulin action. J. Cell. Biochem. 48:1992;33-42.
7. Haring H.-U., Kasuga M., White M.F., Crettaz M., Kanh R. Phosphorylation and dephosphorylation of the insulin receptor: evidence against an intrinsic phosphatase activity. Biochemistry. 23:1984;3298-3306.
8. Phan-Dinh-Tuy F., Herry J., Kahn A. Characterization of human red blood cell tyrosine kinase. Biochem. Biophys. Res. Commun. 126:1985;304-312.
9. Zang W.-R., Goldstein B.J. Identification of skeletal muscle protein-tyrosine phosphatases by amplification of conserved cDNA sequences. Biochem. Biophys. Res. Commun. 178:1991;1291-1297.
10. Worm D., Vinten J., Staehr P., Henriksen J.E., Handberg A., Beck-Nielsen H. Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects. Diabetologia. 39:1996;1208-1214.
11. Ahmad F., Goldstein B.J. Alterations in specific protein-tyrosine phosphatases accompany insulin resistance of streptozotocin diabetes. Am. J. Physiol. 268(Endocrinol. Metab. 31):1995;E932-E940.
12. Ahmad F., Azevedo J.L. Jr, Cortright R., Dohm G.L., Goldstein B.J. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. J. Clin. Invest. 100:1997;449-458.
13. Goren H.J., Boland D. The 180 000 molecular weight plasma membrane insulin receptor substrate is a protein tyrosine phosphatase and is elevated in diabetic plasma membranes. Biochem. Biophys. Res. Commun. 180:1991;463-469.
14. Lau K.-H.W., Farley J.R., Baylink D.J. Phosphotyrosyl protein phosphatases. Biochem. J. 257:1989;23-36.
15. Goldstein B.J. Protein-tyrosine phosphatases. Sheterline P. Tyrosine Phosphoprotein Phosphatases. 2nd ed:1998;3-10 Oxford University Press, New York.
16. Fonda M.L., Zhang Y. Kinetic mechanism and divalent metal activation of human erythrocyte pyridoxal phosphatase. Arch. Biochem. Biophys. 320:1995;345-352.
17. Drake P.G., Posner B.I. Insulin receptor-associated protein tyrosine phosphatase(s): role in insulin action. Mol. Cell. Biochem. 182:1998;79-89.
18. Dissing J., Dahl O., Svensmark O. Phosphonic and arsonic acids as inhibitors of human red cell acid phosphatase and their use in affinity chromatography. Biochim. Biophys. Acta. 569:1979;159-176.
19. Usui H., Kinohara N., Yoshikawa K., Imazu M., Imaoka T., Takeda M. Phosphoprotein phosphatases in human erythrocyte cytosol. J. Biol. Chem. 258:1983;10455-10463.
20. Dissing J., Johnsen A.H., Sensabaugh G.F. Human red cell acid phosphatase (ACP1). J. Biol. Chem. 266:1991;20619-20625.
21. Harrison M.L., Rathinavelu P., Arese P., Geahlen R.L., Low P.S. Role of band 3 tyrosine phosphorylation in the regulation of erythrocyte glycolysis. J. Biol. Chem. 266:1991;4106-4111.
22. Low P.S., Kiyatkin A., Li Q., Harrison M.L. Control of erythrocyte metabolism by redox-regulated tyrosine phosphatases and kinases. Protoplasma. 184:1995;196-202.
23. Zipser Y., Kosower N.S. Phosphotyrosine phosphatase associated with band 3 protein in the human erythrocyte membrane. Biochem. J. 314:1996;881-887.
24. Zipser Y., Piade A., Kosower N.S. Erythrocyte thiol status regulates band 3 phosphotyrosine level via oxidation/reduction of band 3-associated phosphotyrosine phosphatase. FEBS Lett. 406:1997;126-130.
25. Marques F., Crespo M.E., Silva Z.I., Bicho M. Redox modulation of reductase and phosphatase activities in human erythrocytes. Protoplasma. 206:1999;168-173.
26. Clari G., Libera L.D., Moret V. Tyrosine phosphorylation of cytosolic proteins in human erythrocytes. Biochem. Biophys. Res. Commun. 166:1990;1378-1383.
27. Boivin P., Galand C. The human red cell acid phosphatase is a phosphotyrosine protein phosphatase which dephosphorylates the membrane protein band 3. Biochem. Biophys. Res. Commun. 134:1986;557-564.
28. Boivin P. Role of the phosphorylation of red blood cell membrane proteins. Biochem. J. 256:1988;689-695.
29. Marques F., Crespo M.E., Bicho M. Control of NADH ferricyanide reductase activity in the human erythrocyte by somatotrophin and insulin. Redox Rep. 1:1995;113-117.
30. Marques F., Crespo M.E., Pantaleão O., Bicho M. Insulin activation of NADH ferricyanide reductase in human erythrocytes is mediated by the insulin receptor tyrosine kinase: a comparative study in normal and diabetic states. Redox Rep. 2:1996;373-378.
31. Board P.G. NADH-ferricyanide reductase, a convenient approach to the evaluation of NADH-methaemoglobin reductase in human erythrocytes. Clin. Chim. Acta. 109:1981;233-237.
32. van Kampen E.J., Zijlstra W.G. Standardization of hemoglobinometry: the hemoglobincyanide method. Clin. Chim. Acta. 6:1961;538-544.
33. Gambhir K.K., Archer J.A., Bradly C.J. Characteristics of human erythrocyte insulin receptors. Diabetes. 27:1978;701-708.
34. Dons R.F., Ryan J., Gorden P., Wachslicht-Rodbard H. Erythrocyte and monocyte insulin binding in man: a comparative analysis in normal and disease states. Diabetes. 30:1981;896-902.
35. Bottini F.G., Gerlini G., Lucarini N., Borgiani P., Amante A. et al. Phosphotyrosine protein phosphatases and diabetic pregnancy: an association between low molecular weight acid phosphatase and degree of glycemic control. Experientia. 52:1996;340-343.
36. Grigorescu F., Flier J.S., Kahn R. Characterization of binding and phosphorylation defects of erythrocyte insulin receptors in type A syndrome of insulin resistance. Diabetes. 35:1986;127-138.
37. Yki-Järvinen H. Acute and chronic effects of hyperglycaemia on glucose metabolism. Diabetologia. 33:1990;579-585.